Nurea
5
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
40.0%
2 terminated/withdrawn out of 5 trials
33.3%
-53.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation
Role: collaborator
REGISTRY for the Use of a Software for Automatic Detection of the Evolution of Aneurysmal Volume and Graft Migration After EVAR (EndoVascular Aneurysm Repair)
Role: collaborator
Comparison of a Full Automatic Software With Standard Methods of Vessels Analysis
Role: lead
Comparative Study of a Software With the Gold Standard
Role: lead
Validation of a Software and the Follow-up of Anteropoterior Migration of Stent
Role: lead
All 5 trials loaded